Cover Image

Fingolimod treatment at ART initiation delays SIV rebound after ART interruption

Saved in:

Bibliographic Details
Main Authors:	M. Pino (Author), C. King (Author), I. Shim (Author), H. Wang (Author), K. Nguyen (Author), S. Samer (Author), J. Harper (Author), J. Lifson (Author), A. Reynaldi (Author), C. Deleage (Author), K. Padhan (Author), B. Cervasi (Author), M.P. Davenport (Author), C. Petrovas (Author), M.M. Lederman (Author), M. Paiardini (Author)
Format:	Book
Published:	Elsevier, 2019-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

OP 8.4 - 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption
by: H. King, et al.
Published: (2022)

Virologic and immunologic correlates of viral control after ART-interruption in SIV-infected rhesus macaques
by: M. Paiardini, et al.
Published: (2015)

OA4-1 Combined IL-21 and IFNα treatment limits residual inflammation, viral persistence and delays viral rebound in SIV-infected rhesus macaques
by: L. Micci, et al.
Published: (2017)

PP 8.7 - 00098 The sequestration and expansion of effector lymphocytes in lymphoid tissue using combination FTY720 and N-803 immunotherapy at ART initiation fails to limit SIV persistence
by: J. Harper, et al.
Published: (2022)

OA4-5 LB SIV persistence in ART-treated infant rhesus macaques
by: M. Mavigner, et al.
Published: (2016)

Utilising correlative PET/CT and multiscale imaging to define the dynamics of SIV-infected cells from early ART initiation to the rebound after analytic treatment interruption
by: T. Hope, et al.
Published: (2019)

Peripheral blood SIV/HIV originates from infected cells in tissues
by: M. Betts, et al.
Published: (2019)

OA4-3 PD-1 blockade combined with ART improves SIV-specific CD8 T cell function and enhances control of pathogenic SIV after ART interruption
by: G.H. Mylvaganam, et al.
Published: (2016)

PP 2.3 - 00034 CD8+ T-Cell Sieving During SIV Reactivation from Latency
by: S. Docken, et al.
Published: (2022)

PP 2.11 - 00144 Transcriptional and translational SIV profiles of peripheral and lymphoid CD4+ T cells of viremic and ART-suppressed Rhesus macaques
by: M. Nayrac, et al.
Published: (2022)

Origin of rebound virus in chronically SIV-infected monkeys following treatment discontinuation
by: D. Barouch, et al.
Published: (2019)

OP 2.2 - 00200 Characterization of the SIV tissue reservoir transcriptional environment at the single focus level during ART and post ATI
by: M. Arif, et al.
Published: (2022)

The latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques is potentiated by CD8a cell depletion
by: M. Mavigner, et al.
Published: (2019)

PP 4.18 - 00213 Dynamics and antiviral role of TOX+ TCF1+ CD39+ CD8 T cells in lymphoid tissue of SIV-infected rhesus macaques
by: Z. Strongin, et al.
Published: (2022)

OP 2.5 - 00048 Targeting the SIV reservoir with Alemtuzumab
by: B. Varco-Merth, et al.
Published: (2022)

Safety of generic fingolimod
by: O. M. Koval, et al.
Published: (2018)

PP 2.15 - 00169 Macrophages are the primary source of virus in semen and male genital tract organs in acutely and chronically infected rhesus macaques
by: C. Deleage, et al.
Published: (2022)

Brain macrophages in SIV-infected ART-suppressed macaques represent a functional latent reservoir
by: J. Clements, et al.
Published: (2017)

Defining HIV and SIV Reservoirs in Lymphoid Tissues
by: Claire Deleage, et al.
Published: (2016)

Barcoded viruses facilitate tracking changes to the composition of the rebound-competent reservoir
by: B. Keele, et al.
Published: (2019)

4 Post-treatment control or treated controllers? The impact of ART on time to viral rebound in recent seroconverters
by: G.E. Martin, et al.
Published: (2016)

CD8 depletion plus signaling of the non-canonical NF-kB pathway reverses latency in SIV-infected, ART-suppressed rhesus macaques
by: M. Mavigner, et al.
Published: (2019)

The effects of combination of ingenol-B and ART to SIV251 infected rhesus monkeys
by: G. dos Santos Goncalves, et al.
Published: (2015)

PP 8.1 - 00003 Optimization of the 5' cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART
by: W. Omange, et al.
Published: (2022)

PP 7.10 - 00088 Macrophage-Tropic HIV-1 Variants Contribute to Pediatric Rebound Viremia off ART
by: K. Ganta, et al.
Published: (2022)

OP 6.7 - 00044 Long-term ART-free SIV Remission Following Allogeneic Hematopoietic Cell Transplantation in Mauritian Cynomolgus Macaques
by: H. Wu, et al.
Published: (2022)

PP 4.17 - 00198 Peripheral Blood Biomarkers of Occult Infection in ART-Suppressed, SIV-Infected Rhesus Macaques
by: M. Boudries, et al.
Published: (2022)

Severe rebound disease activity after fingolimod withdrawal in a pregnant woman with multiple sclerosis managed with rituximab: A case study
by: Beatriz Canibaño, et al.
Published: (2020)

Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
by: A.A. Okoye, et al.
Published: (2019)

Quantitation of the CD4+ T cell and macrophage reservoirs in SIV-infected ART-suppressed macaques: two functional latent reservoirs
by: J. Clements, et al.
Published: (2017)

PP 2.14 - 00162 Elucidating the effects of combination therapy with Venetoclax and IAP inhibitor AZD5582 in SIV-infected, ART-suppressed macaques
by: B. Ukhueduan, et al.
Published: (2022)

Oral TLR7 agonist administration induces an immunostimulatory response in SIV-infected ART-suppressed infant rhesus macaques
by: K. Bricker, et al.
Published: (2019)

Partial control of viral rebound with a Rev-dependent lentiviral vector carrying HSV-tk gene in SIV-infected rhesus macaques
by: Y. Wu, et al.
Published: (2017)

SIV persists in lymphoid tissues despite alemtuzumab-induced CD4+ T cell depletion
by: A.A. Okoye, et al.
Published: (2017)

In vivo suppression of SIV-mediated immune activation by a p38 MAPK inhibitor combined with ART
by: A. Aldovini, et al.
Published: (2015)

PP 1.38 - 00212 Characterization of SIV infected mast cells in early foci of rebound after ATI and HIV infection of primary mast cells in tissue culture models reveals an important new player in viral persistence and pathogenesis
by: T. Hope, et al.
Published: (2022)

Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy
by: B. Ling, et al.
Published: (2017)

SIV-specific CD8 T cells are largely excluded from B cell follicles during early SIV infection
by: S. Li, et al.
Published: (2017)

Fully MHC-matched allogeneic hematopoietic stem cell transplantation in SIV-infected, cART-suppressed Mauritian cynomolgus macaques indicates GVHD as a reservoir clearance mechanism
by: H.L. Wu, et al.
Published: (2017)

Sustained SHIV reactivation by N-803 in ART-treated CD8-depleted macaques
by: J.B. McBrien, et al.
Published: (2019)